FR-182024 | m-entrepreneurship.com

Product Name :
FR-182024

Search keywords :
FR182024

drugId :
null

Target Vo:
Bacterial penicillin-binding protein

Target Vo Short Name :
PBPs

Moa_Name:
Bacterial penicillin-binding protein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Fujisawa Pharmaceutical Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Bacterial Infections

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD73 Rabbit mAb In Vitro
Cofetuzumab pelidotin manufacturer
Phospho-AMPK alpha 1 (Ser496) Antibody: Phospho-AMPK alpha 1 (Ser496) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 64 kDa, targeting to Phospho-AMPK alpha 1 (Ser496). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts